keyword
MENU ▼
Read by QxMD icon Read
search

Antiphospholid Syndrome

keyword
https://www.readbyqxmd.com/read/26387759/-natural-history-of-portal-cavernoma-without-liver-disease-a-single-centre-retrospective-study-of-32%C3%A2-cases
#1
A S Resseguier, M André, E A Orian Lazar, G Bommelaer, O Tournilhac, I Delèvaux, M Ruivard, M D'Incan, L Boyer, O Aumaître
PURPOSE: Portal cavernoma follows a chronic occlusion of the portal vein. The long-term consequences of portal cavernoma are not well known. The objective of this study was to report the aetiology of the portal cavernoma and its natural course after excluding liver diseases causes. METHODOLOGY: A single centre retrospective study based on the data collected from the radiology department of the Clermont-Ferrand hospital was conducted from 2000 to 2011. All the patients for whom an imagery found a portal cavernoma have been looked for excluding the patients having a liver disease whatever the aetiology and the Budd-Chiari syndrome...
June 2016: La Revue de Médecine Interne
https://www.readbyqxmd.com/read/26318678/delineating-the-deranged-immune-system-in-the-antiphospholipid-syndrome
#2
REVIEW
Lucas L van den Hoogen, Joël A G van Roon, Timothy R D J Radstake, Ruth D E Fritsch-Stork, Ronald H W M Derksen
The antiphospholipid syndrome (APS) is a systemic autoimmune disease that is characterized serologically by the presence of antiphospholipid antibodies (aPL) and clinically by vascular thrombosis and obstetric complications. The protein β2 glycoprotein I (β2GPI) is identified as the most important autoantigen in this syndrome. Activation of endothelial cells, thrombocytes and placental tissue by anti-β2GPI antibodies relates to the clinical manifestations of APS. This review describes genetic and environmental factors in relation to APS and summarizes the current knowledge on abnormalities in components of both the innate and adaptive immune system in APS...
January 2016: Autoimmunity Reviews
https://www.readbyqxmd.com/read/24128160/cardiovascular-comorbidities-in-antiphospholipid-syndrome
#3
REVIEW
Cezar A Muniz Caldas, Jozélio Freire de Carvalho
Antiphospholipid syndrome is an autoimmune disease characterized by venous and/or arterial thrombosis and/or recurrent fetal loss and the presence of antiphospholid antibodies. Among the causes of death of antiphospholipid syndrome there are the myocardial infarction and stroke. Comorbidities could worsen the evolution of these patients, and the knowledge about these situations could prevent or minimizethe risks associated with the disease. In this article, we review the literature about cardiovascular comorbidities, such as traditional risk factors for atherosclerosis, metabolic syndrome and vitamin D deficiency, and how these could influence the prognosis of antiphospholipid syndrome patients...
October 2013: Expert Review of Clinical Immunology
https://www.readbyqxmd.com/read/22826113/the-long-term-marriage-between-autoimmunity-and-internal-medicine-a-homage-to-manuel-carlos-dias
#4
REVIEW
Carlo Selmi, M Eric Gershwin
Our understanding of autoimmune diseases results from the perfect combination of basic and clinical scientific research, and the figure that is closest to the proposed autoimmunology specialist is certainly the internist. The role of B cells in rheumatoid arthritis, the immunological mechanisms to fibrosis or to tissue specific damage, the classification of Bechet's syndrome, the clinical outcomes of antiphospholid syndrome, and new biomarkers for vascular complications in systemic sclerosis constitute, among others, are ideal examples of this combination...
December 2012: Clinical Reviews in Allergy & Immunology
https://www.readbyqxmd.com/read/21557460/antiphospholid-antibody-syndrome-and-hb-e-beta-thalassemia-disease-post-allogeneic-stem-cell-transplantation
#5
Nongnuch Sirachainan, Samart Pakakasama, Suradej Hongeng, Ampaiwan Chuansumrit, Lojana Tuntiyatorn, Soamarat Vilaiyuk
We report a 10-year-old male with Hb E/Beta thalassemia disease who developed chronic graft-versus-host disease (cGVHD) of antiphospholipid antibody syndrome after successful allogeneic stem cell transplantation (SCT). He exhibited a recurrent ischemic stroke on day 368 post-SCT while on cyclosporine A, azathioprine, and prednisolone. The immunosuppressive agents were switched to pulse methylprednisolone, tacolimus, mycophenolate mofetil, and enoxaparin, but the patient was more confused. An additional plasma exchange which was aimed at the immediate removal of autoantibody was performed with a good response...
July 15, 2011: Pediatric Blood & Cancer
https://www.readbyqxmd.com/read/17331625/-auto-immune-hepatitis-and-antiphospholipids
#6
S Branger, N Schleinitz, V Veit, C Martaresche, M Bourlière, X Roblin, S Garcia, M San Marco, L Camoin, J-M Durand, J-R Harlé
INTRODUCTION: Only few series have reported the association of autoimmune hepatitis with antiphospholipid antibodies. The aim of our study is to investigate the frequency of these antibodies in a series of autoimmune hepatitis and to search for a correlation with clinical, biological or histological characteristics. MATERIAL AND METHODS: Antiphospholipid were investigated in 24 patients with well defined autoimmune hepatitis. Characteristics were compared between antiphopholipids positive and negative patients...
April 2007: La Revue de Médecine Interne
https://www.readbyqxmd.com/read/16447744/-antiphospholipid-syndrome-and-stroke
#7
Yasuhisa Kitagawa
Antiphospholipid syndrome is characterized by arterial or venous thrombosis, and the presence of antiphospholipid antibodies (aPL). APL are considered to be a cause of an acquired hypercoagulable state leading to stroke and transient ischemic attack (TIA). We examined the causes in 50 young patients with ischemic stroke. The most prevalent cause was atherosclerosis and the incidence of APS was 12.5%. APL comprise a heterogeneous group of autoantibodies, such as beta2-glycoprotein I dependent anticardiolipin antibody (beta2-GPIaCL), lupus anticoagulant (LA), and other antiphospholid-protein antibodies...
November 2005: Rinshō Shinkeigaku, Clinical Neurology
https://www.readbyqxmd.com/read/16104622/-acute-myocardial-infarction-complicating-primary-antiphospholipid-syndrome-after-aspirin-and-steroids-withdrawal
#8
K Wahbi, E Salengro, L Galicier, L Guillevin, C Spaulding, S Weber, C Meune
A 24-year-old woman, with known antiphospholid antibodies (APS), presented with an acute myocardial infarction (AMI) that occurred three months after delivery. No risk factors for arteriosclerosis and no past history of arterial/venous thrombosis were noted. During pregnancy, aspirin prophylaxis was prescribed and followed by steroids after caesarian section. Steroids withdrawal was followed by AMI. Immediate coronary angiography revealed thrombotic occlusion of the left descending coronary artery; PTCA was successfully performed...
August 2005: Annales de Cardiologie et D'angéiologie
https://www.readbyqxmd.com/read/15210401/effectivity-of-heparin-in-assisted-reproduction
#9
REVIEW
Klaus Fiedler, Wolfgang Würfel
Disturbances of the embryo-maternal interaction, i.e. impaired implantation, are seen in only a minor fraction of couples. These malfunctions become evident as recurrent spontaneous abortions (RSA), or repetitive implantation failure (RIF) in cases with IVF or ICSI procedures. The antiphospholipid syndrome (APL) is the only consensus-defined syndrome associated with RSA (anticardiolipin antibodies and/or lupus anticoagulant plus clinical symptoms). Since antiphospholipid antibodies directly interfere with hemostasis (increased coagulation), heparin is an established treatment option in these cases resulting in unequivocal benefits...
April 30, 2004: European Journal of Medical Research
https://www.readbyqxmd.com/read/14598587/-antibodies-to-beta2-glycoprotein-i-and-antibodies-to-cardiolipin-in-antiphospholipid-syndrome-analysis-of-sensitivity-and-specificity
#10
E N Aleksandrova, A A Novikov, T M Reshetniak, H G Kliukvina, D V Reshetniak, E L Nasonov
To study sensitivity and specificity of antibodies to beta 2-glycoprotein I (B2GP-I) and antibodies to cardiolipin (CL) in diagnosis of antiphospholipid syndrome (APS), we examined 19 patients with primary antiphospholid syndrome (PAPS), 23 patients with secondary APS (SAPS) and systemic lupus erythematosus (SLE) and 73 patients with SLE. Antibodies to B2GP-I and CL of IgG isotype were measured at enzyme immunoassay. The levels of IgG aCL and IgG aB2GP-I in the serum of PAPS patients were 69.9 +/- 116.0 GPL, 74...
2003: Klinicheskaia Meditsina
https://www.readbyqxmd.com/read/12098096/-complicated-antiphospholid-antibody-syndrome
#11
F Langer, B Eifrig, S Hegewisch-Becker, G Marx, K Neuber, D K Hossfeld
HISTORY AND CLINICAL FINDINGS: A 51-year-old female patient suffered from recurrent ischemic strokes and venous thromboembolism although treated with ASS and phenprocoumon, which mainly occurred after diagnosis and treatment of an invasive-ductal mamma carcinoma. The severely ill patient presented with right-sided hemiparesis and dysarthria, a swollen leg, a painful necrotic-ulcerative lesion at the left-lateral ankle and a systolic heart murmur. INVESTIGATIONS: Laboratory data revealed a haemoglobin of 8,4 g/dl, a leucocyte count of 3,1 x 10 (9)/l and a platelet count of 87 x 10 (9)/l...
July 5, 2002: Deutsche Medizinische Wochenschrift
https://www.readbyqxmd.com/read/11937138/antiphospholid-antibodies-regulate-the-expression-of-trophoblast-cell-adhesion-molecules
#12
Nicoletta Di Simone, Roberta Castellani, Dario Caliandro, Alessandro Caruso
OBJECTIVE: To examine the effect of antiphospholipid antibodies on trophoblast expression of adhesion molecules. DESIGN: Primary cytotrophoblast cell cultures. SETTING: Department of Obstetrics and Gynecology, Catholic University, Rome, Italy. PATIENT(S): Five normal pregnant women underwent uncomplicated vaginal delivery at 36 weeks of gestation. INTERVENTION(S): IgG antibodies were isolated from a patient with antiphospholipid syndrome and from a normal control subject, using protein-G Sepharose columns...
April 2002: Fertility and Sterility
https://www.readbyqxmd.com/read/8977809/-prevalence-and-role-of-anticardiolipin-antibodies-in-crohn-disease
#13
COMPARATIVE STUDY
I Lonjon, L Beaugerie, A Deschamps, C Barthet, F Carbonnel, Y Ngô, J Cosnes, N Abuaf, J P Gendre
OBJECTIVES: Anticardiolipin antibodies belong to the group of antiphospholid antibodies, and may be seen in association with endothelial damage and recurrent vascular thrombosis. The aim of our study was to determine in patients with Crohn's disease the frequency of anticardiolipin antibodies, and to correlate their presence with clinical activity and treatment of the disease. METHODS: One hundred and thirty-eight sera from patients with Crohn's disease and 118 from age-matched controls were tested for IgG anticardiolipin antibodies...
1996: Gastroentérologie Clinique et Biologique
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"